Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide. [electronic resource]
Producer: 20010426Description: 2913-6 p. digitalISSN:- 0022-1767
- Abatacept
- Animals
- Antigens, CD
- Antigens, Differentiation -- therapeutic use
- Autoantibodies -- biosynthesis
- CTLA-4 Antigen
- Cyclophosphamide -- therapeutic use
- Drug Therapy, Combination
- Female
- Humans
- Immunoconjugates
- Immunoglobulin G -- biosynthesis
- Immunosuppressive Agents -- therapeutic use
- Lupus Nephritis -- drug therapy
- Lymphocyte Count
- Lymphocyte Subsets -- pathology
- Mice
- Mice, Inbred NZB
- Proteinuria -- drug therapy
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.